logo

For the Inventor, By the Inventor

Warminster, PA, United States of America

David F McComsey

This inventor holds 34 USPTO granted patents and 1 published patent application and 3 EPO patents, primarily in Kinase Inhibitors. Top assignees: Janssen Pharmaceutica Nv, Ortho-Mcneil Pharmaceutical Corp., Mcneil Ab. Active years: 1983-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David F McComsey. Retrieved from https://idiyas.com/inventor/david-f-mccomsey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34 

% Patents Active = 52.9

 

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 104(Granted Patents)


Location History:

  • Warminser, PA (US) (2005 - 2007)
  • Warminister, PA (US) (2011)
  • Warminster, PA (US) (1983 - 2015)

Company Filing History:

goldMedal13 out of 2,101 
 
Janssen Pharmaceutica Nv
 patents
silverMedal13 out of 363 
 
Ortho-Mcneil Pharmaceutical Corp.
 patents
bronzeMedal3 out of 189 
 
Mcneil Ab
 patents
4. 2 out of 854 
 
Millennium Pharmaceuticals Limited
 patents
5. 1 out of 32 
 
Janssen Pharmaceutica
 patents
6. 1 out of 377 
 
Ortho Pharmaceutical Corporation
 patents
7. 1 out of 1 
 
Ortho-Mcneil-Janssen Pharmaceuticals, Inc.
 patent
8. 2 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1983-2015

Loading Chart...
Loading Chart...
Areas of Expertise:
Kinase Inhibitors
Thrombin Receptor Antagonists
Epilepsy Treatments
Pyrroline Compounds
Sulfamide Derivatives
Urotensin II Antagonists
Peptidomimetics
CNS Disorders
Hexahydro Compounds
Acyl-Tripeptides
Anticonvulsants
Indole Derivatives
34 patents (USPTO):Explore Patents
1. 9024017 - Octahydro-cyclopentapyrrolyl antagonists of CCR2 (2015-05-05),
2. 8853263 - Co-therapy for the treatment of epilepsy and related disorders (2014-10-07),
3. 8815939 - Substituted sulfamide derivatives (2014-08-26),
4. 8445514 - Urotensin II receptor antagonists (2013-05-21),
5. 8084490 - Sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders (2011-12-27),
6. 8008299 - Urotensin II receptor antagonists (2011-08-30),
7. 7855203 - Indazolyl-substituted pyrroline compounds as kinase inhibitors (2010-12-21),
8. 7786135 - Substituted pyrroline kinase inhibitors (2010-08-31),
9. 7781450 - Substituted pyrroline kinase inhibitors (2010-08-24),
10. 7759380 - Substituted pyrrolines as kinase inhibitors (2010-07-20),
11. 7705015 - Substituted pyrroline kinase inhibitors (2010-04-27),
12. 7608634 - Substituted pyrrolines as kinase inhibitors (2009-10-27),
13. 7524858 - Substituted pyrroline kinase inhibitors (2009-04-28),
14. 7329657 - Indazolyl-substituted pyrroline compounds as kinase inhibitors (2008-02-12),
15. 7312306 - Substituted heterocyclic acyl-tripeptides useful as thrombin receptor modulators (2007-12-25),

Title: The Innovative Journey of David F McComsey: Pioneering Solutions in Healthcare

Introduction: David F McComsey, a prolific inventor hailing from Warminster, PA, has left an indelible mark on the field of healthcare with his groundbreaking patents and inventive spirit. With an impressive portfolio of 34 patents to his name, McComsey's contributions have significantly impacted the treatment of various conditions, ranging from type II diabetes to epilepsy.

Latest Patents: Among his latest patents, McComsey has introduced revolutionary compounds aimed at combating disorders such as type II diabetes, obesity, and asthma by inhibiting CCR2 activity in mammals. Additionally, his co-therapy approach for the treatment of epilepsy and related disorders showcases his commitment to developing innovative treatment strategies for complex medical conditions.

Career Highlights: McComsey's professional journey has seen him collaborate with notable pharmaceutical companies such as Ortho-McNeil Pharmaceutical Corp and Janssen Pharmaceutica NV. His tenure in these renowned organizations has provided him with the platform to translate his inventive ideas into tangible solutions that have the potential to transform healthcare practices.

Collaborations: Throughout his career, McComsey has worked alongside esteemed colleagues such as Bruce E Maryanoff and Han-Cheng Zhang. This collaborative effort has been instrumental in fostering a creative environment where novel ideas flourish, ultimately leading to the development of pioneering medical interventions.

Conclusion: In conclusion, David F McComsey stands as a beacon of innovation in the realm of healthcare, with his patents serving as a testament to his unwavering dedication to advancing medical science. His relentless pursuit of novel solutions and collaborative spirit underscore the importance of teamwork in driving impactful innovations that have the power to enhance the quality of healthcare delivery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…